Team at Fudan University develops companion diagnostics for non-small lung cancer (NSLC) treatment

The group around Du XIANG at Fudan University Cancer Hospital is using the anaplastic lymphoma kinase (ALK) gene as a marker for the early identification of NSLC which support appropriate therapy.

China Bio news release, June 16, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny